<bill session="116" type="s" number="1505" updated="2019-09-17T04:42:29Z">
  <state datetime="2019-05-16">REFERRED</state>
  <status>
    <introduced datetime="2019-05-16"/>
  </status>
  <introduced datetime="2019-05-16"/>
  <titles>
    <title type="official" as="introduced">A bill to require prescription drug plans and MA-PD plans to report potential fraud, waste, and abuse to the Secretary of Health and Human Services under Medicare part D, and for other purposes.</title>
    <title type="short" as="introduced">Medicare Prescription Drug Fraud Prevention Act of 2019</title>
    <title type="short" as="introduced">Medicare Prescription Drug Fraud Prevention Act of 2019</title>
    <title type="display">Medicare Prescription Drug Fraud Prevention Act of 2019</title>
  </titles>
  <sponsor bioguide_id="C001056"/>
  <cosponsors>
    <cosponsor bioguide_id="C000141" joined="2019-05-16"/>
  </cosponsors>
  <actions>
    <action datetime="2019-05-16">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2019-05-16" state="REFERRED">
      <text>Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSFI" name="Senate Finance" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Fraud offenses and financial crimes"/>
    <term name="Government information and archives"/>
    <term name="Health care costs and insurance"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <committee-reports/>
</bill>
